What should I do first after my insurance denies Zepbound or Wegovy?

Request the denial reason in writing, ask for the plan's medical-necessity criteria, and ask for the appeal deadline. Denials are often appealable and appeals frequently go unfiled.

Can I buy Wegovy or Zepbound without insurance?

Yes. NovoCare sells the Wegovy pen direct for $349 a month flat across standard doses, and LillyDirect sells Zepbound for $449 a month at maintenance doses with a 45-day refill condition, as of DoseTruth's last weekly audit.

Should I use a pharmacy discount coupon after a denial?

Usually not for these two drugs. Couponed Wegovy runs about $1,229 to $1,419 a month at the counter, roughly four times the manufacturer's direct cash price.

DoseTruth

The weekly audit →

Insurance denied Zepbound or Wegovy

Denied? You have more moves than the letter suggests.

A denial is a step in a process, not the end of it. Here are the three moves that matter, free, from the team that audits all 21 GLP-1 pricing programs every Monday. No signup needed to read this.

MOVE 1

Get the denial reason in writing, this week

Call the number on your insurance card and ask three questions, word for word:

"What is the exact reason for the denial, in writing?"
"What are your medical-necessity criteria for this medication?"
"What is the appeal process, and what is my deadline?"

Denials are often appealable, and appeals frequently go unfiled. An approved appeal can drop your cost to a $25 monthly savings-card copay on eligible commercial plans.

MOVE 2

Start a cash path in parallel, don't wait on the appeal

Appeals take weeks. Manufacturer-direct cash pricing exists right now and needs no insurance at all:

Wegovy pen, direct from NovoCare: $349 a month, flat across standard doses
Zepbound, direct from LillyDirect: $449 a month at maintenance doses, if you refill within 45 days
Oral options run $199 to $299 a month at maintenance doses

Run the appeal and the cash path at the same time. If the appeal wins, switch.

The $1,300 mistake

The common wrong move after a denial: walking into a pharmacy with a discount coupon. Couponed Wegovy runs $1,229 to $1,419 a month at the counter. That is nearly four times the manufacturer's own direct price. The denial hurts once. This mistake hurts every month.

Want your exact situation worked out by a human?

The guarantee comes first: if the report does not identify at least $39 in monthly savings versus what you pay today, reply within 30 days for a full refund. If you simply don't like it, same answer, same 30 days.

The Personal Access Report is $39. Within 24 hours you get:

Your 3 cheapest legitimate paths of the 21 programs we track, with the real monthly math for your medication and insurance situation
Your first-level appeal outline and the insurer script, word for word
The traps that apply to you: refill windows, billing lumps, teaser pricing

Get my report, $39 Or take the 90-second quiz first

Common questions after a denial

Is appealing actually worth the effort?

Often, yes. The gap between outcomes is large: an approved appeal can mean a $25 monthly copay with a savings card, versus $349 to $449 a month cash, versus $1,200+ at a pharmacy counter. The appeal costs a phone call and a letter.

How long does an appeal take?

Plans publish their own decision timelines, commonly measured in weeks. Ask for yours in the same call where you request the written denial reason. That is why we suggest starting a cash path in parallel rather than waiting.

Can I just buy it without insurance?

Yes. Both manufacturers sell direct to cash payers with no insurance requirement: NovoCare for Wegovy, LillyDirect for Zepbound. The prices above are their published rates as of our last weekly check.

Is this medical advice?

No. This page is about prices and paperwork. Whether a GLP-1 is right for you is a decision for you and your licensed healthcare provider.

DoseTruth is pricing information, not medical advice. Prices are estimates from published program pages as of our last weekly audit and can change without notice. Insurance outcomes are estimates, not guarantees. All product names are trademarks of their respective owners, used for identification only. © 2026 DoseTruth, operated by KY Solutions.